Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Dx, IDB Resources Ink Tumor Profiling Distribution Agreement for Southeast Asia

NEW YORK (GenomeWeb) – Phoenix-based tumor profiling firm Paradigm Diagnostics has signed an exclusive distribution agreement with IDB Resources for Malaysia, Singapore, and Brunei.

Under the terms of the agreement, Malaysia-based IDB Resources will provide access to Paradigm's PCDx next-generation sequencing clinical tumor profiling service. The test offers information on potential therapies based on the characterization of the patient's tumor genome.

"We are excited to continue expansion of Paradigm's testing services outside the US," Paradigm President David Mallery said in a statement. "IDB Resources provides us with an experienced team to help realize growth in these markets over the short term."

IDB Resources is based in Petaling Jaya, Malaysia.

Financial and other terms of the agreement were not disclosed.

The Scan

Genetic Ancestry of South America's Indigenous Mapuche Traced

Researchers in Current Biology analyzed genome-wide data from more than five dozen Mapuche individuals to better understand their genetic history.

Study Finds Variants Linked to Diverticular Disease, Presents Polygenic Score

A new study in Cell Genomics reports on more than 150 genetic variants associated with risk of diverticular disease.

Mild, Severe Psoriasis Marked by Different Molecular Features, Spatial Transcriptomic Analysis Finds

A spatial transcriptomics paper in Science Immunology finds differences in cell and signaling pathway activity between mild and severe psoriasis.

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.